Vertebral aspergillosis in a patient with autosomal-dominant hyper-IgE syndrome

Clinical and Vaccine Immunology

Volumn 21, Issue 1, 2014, Pages 107-109

  Ma, Hong ^a   Kuang, Lei ^a   Lv, Guohua ^a   Wang, Bing ^a   Lian, Zhesi ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFATHIAMIDINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; AUTOSOMAL DOMINANT DISORDER; BACTERIAL INFECTION; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DECOMPRESSION; ENZYME IMMUNOASSAY; EOSINOPHIL; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FINE NEEDLE ASPIRATION BIOPSY; GROWTH RETARDATION; HISTOPATHOLOGY; HUMAN; HYPER IGE SYNDROME; LEUKOCYTE COUNT; LOADING DRUG DOSE; LUNG INFECTION; MALE; NEUROGENIC TUMOR; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; VERTEBRAL ASPERGILLOSIS; WEIGHT REDUCTION;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; DEBRIDEMENT; HISTOCYTOCHEMISTRY; HUMANS; JOB SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY; SPINE; STAT3 TRANSCRIPTION FACTOR;

EID: 84892164942     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00529-13     Document Type: Article

References (10)

1. Li H, Ji CY, Zong XN, Zhang YQ. 2009. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47: 487-492. (In Chinese.) http://dx.doi.org/10.3760/cma.j.issn. 0578-1310.2009.07.003.
2. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448: 1058-1062. http://dx.doi.org/10.1038/nature06096.
3. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schaffer AA, Puck JM, Grimbacher B. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608-1619. http://dx.doi.org/10.1056/ NEJMoa073687.
4. Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM. 2010. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J. Allergy Clin. Immunol. 125: 1389-1390. http://dx.doi.org/10.1016/j.jaci.2010.01.047.
5. Minegishi Y, Karasuyama H. 2009. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int. Immunol. 21: 105-112. http://dx.doi.org/10.1093/intimm/dxn134.
6. Dayan L, Sprecher H, Hananni A, Rosenbaum H, Milloul V, Oren I. 2007. Aspergillus vertebral osteomyelitis in chronic leukocyte leukemia patient diagnosed by a novel panfungal polymerase chain reaction method. Spine J. 7: 615-617. http://dx.doi.org/10.1016/j.spinee.2006.08.005.
7. Vinas FC, King PK, Diaz FG. 1999. Spinal aspergillus osteomyelitis. Clin. Infect. Dis. 28: 1223-1229. http://dx.doi.org/10.1086/514774.
8. Lin SJ, Schranz J, Teutsch SM. 2001. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 32: 358-366. http://dx.doi.org/10.1086/318483.
9. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of A. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46: 327-360. http://dx.doi.org/10.1086/525258.
10. Soler-Palacin P, Frick MA, Martin-Nalda A, Lanaspa M, Pou L, Rosello E, de Heredia CD, Figueras C. 2012. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study. J. Antimicrob. Chemother. 67: 700-706. http://dx.doi.org/10.1093/jac/dkr517.